Đang chuẩn bị liên kết để tải về tài liệu:
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Advanced esophageal squamous cell cancer (ESCC) is frequently diagnosed in elderly patients. The impact of 2nd line chemotherapy is poorly defined. Recent data demonstrated effectiveness of checkpoint inhibitors in different squamous cell carcinomas. | A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer RAMONA

TÀI LIỆU LIÊN QUAN

Treatment strategies and prognostic factors of primary gastric diffuse large B cell lymphoma: A retrospective multicenter study of 272 cases from the China lymphoma patient registry

The burden of rotavirus gastroenteritis and hospital-acquired rotavirus gastroenteritis among children aged less than 6 years in Japan: A retrospective, multicenter epidemiological survey

The effectiveness of video interaction guidance in parents of premature infants: A multicenter randomised controlled trial

Infliximab for pediatric patients with ulcerative colitis: A phase 3, open-label, uncontrolled, multicenter trial in Japan

Paravertebral catheter versus EPidural analgesia in Minimally invasive Esophageal resectioN: A randomized controlled multicenter trial (PEPMEN trial)

Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial

Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: A multicenter randomized controlled trial

Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: A multicenter phase II study (TOSA trial) protocol

Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial)

Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: A multicenter double-blind placebo-controlled randomized trial